The Expanding Role of Cancer Stem Cell Marker ALDH1A3 in Cancer and Beyond

Meghan E. McLean, Maya R. MacLean, Hannah F. Cahill, Raj Pranap Arun, Olivia L. Walker, Marie Claire D. Wasson, Wasundara Fernando, Jaganathan Venkatesh, Paola Marcato

Résultat de recherche: Review articleexamen par les pairs

25 Citations (Scopus)

Résumé

Aldehyde dehydrogenase 1A3 (ALDH1A3) is one of 19 ALDH enzymes expressed in humans, and it is critical in the production of hormone receptor ligand retinoic acid (RA). We review the role of ALDH1A3 in normal physiology, its identification as a cancer stem cell marker, and its modes of action in cancer and other diseases. ALDH1A3 is often over-expressed in cancer and promotes tumor growth, metastasis, and chemoresistance by altering gene expression, cell signaling pathways, and glycometabolism. The increased levels of ALDH1A3 in cancer occur due to genetic amplification, epigenetic modifications, post-transcriptional regulation, and post-translational modification. Finally, we review the potential of targeting ALDH1A3, with both general ALDH inhibitors and small molecules specifically designed to inhibit ALDH1A3 activity.

Langue d'origineEnglish
Numéro d'article492
JournalCancers
Volume15
Numéro de publication2
DOI
Statut de publicationPublished - janv. 2023

Note bibliographique

Funding Information:
M.E.M. is funded by a Faculty of Medicine Scholarship and a Nova Scotia Graduate Scholarship. H.F.C. is funded by a Research Nova Scotia Masters Scotia Scholar studentship and a Nova Scotia Graduate Scholarship. O.L.W. is funded by a Killam Predoctoral Scholarship and the President’s Award. M.-C.D.W. is funded by the Research Nova Scotia Scholar Award, a Nova Scotia Graduate Studentship and is supported by the Cancer Research Training Program (CRTP) from the Beatrice Hunter Cancer Research Institute (BHCRI). R.P.A. is a trainee in the CRTP of the BHRCRI, with funds generously provided by the Canadian Cancer Society’s JD Irving, Limited—Excellence in Cancer Research Fund. W.F. is funded by a Dalhousie Medical Research Foundation-I3V Dr. David H. Hubel Postdoctoral Fellowship. J.V. is a trainee in the CRTP of the BHRCRI, with funds generously provided by GIVETOLIVE. The article was funded by grant support to P.M. from the Canadian Institutes of Health Research (CHIR, PJT 162313).

Publisher Copyright:
© 2023 by the authors.

ASJC Scopus Subject Areas

  • Oncology
  • Cancer Research

PubMed: MeSH publication types

  • Journal Article
  • Review

Empreinte numérique

Plonger dans les sujets de recherche 'The Expanding Role of Cancer Stem Cell Marker ALDH1A3 in Cancer and Beyond'. Ensemble, ils forment une empreinte numérique unique.

Citer